Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steffen Koschmieder

Showing results (1-10 of 198) with videos related to

Pageof 20
Sort By:
Hemasphere|December 13, 2024
Novel approaches in myelofibrosisSteffen Koschmieder
Hamostaseologie|February 13, 2020
How I Manage Thrombotic/Thromboembolic Complications in Myeloproliferative NeoplasmsSteffen Koschmieder
American Journal of Blood Research|March 21, 2012
Mouse models as tools to understand and study BCR-ABL1 diseasesSteffen Koschmieder, Mirle Schemionek
Seminars in Cancer Biology|August 6, 2017
Epigenetic dysregulation in chronic myeloid leukaemia: A myriad of mechanisms and therapeutic optionsSteffen Koschmieder, David Vetrie
Blood Reviews|June 8, 2020
Role of inflammation in the biology of myeloproliferative neoplasmsSteffen Koschmieder, Nicolas Chatain
Hamostaseologie|February 3, 2025
Thrombosis at Unusual Sites: Focus on Myeloproliferative Neoplasms and Paroxysmal Nocturnal HemoglobinuriaSteffen Koschmieder, Jens Panse
Oncotargets and Therapy|March 16, 2013
Profile of bosutinib and its clinical potential in the treatment of chronic myeloid leukemiaGunhild Keller-von Amsberg, Steffen Koschmieder
Cancers|August 19, 2020
Role of Inflammatory Factors during Disease Pathogenesis and Stem Cell Transplantation in Myeloproliferative NeoplasmsNicolas Chatain, Steffen Koschmieder, Edgar Jost
Proceedings of the National Academy of Sciences of the United States of America|September 15, 2020
Kindlin-3 loss curbs chronic myeloid leukemia in mice by mobilizing leukemic stem cells from protective bone marrow nichesPeter William Krenn, Steffen Koschmieder, Reinhard Fässler
Dermatologie (Heidelberg, Germany)|June 16, 2026
[Systemic pruritus: focus on hematological, nephrogenic, and hepatobiliary etiologies]Steffen Koschmieder, Marcus Brand, Andreas E Kremer
Pageof 20

Showing results (1-10 of 198) with videos related to

Sort By:
Pageof 20
Hemasphere|December 13, 2024
Novel approaches in myelofibrosisSteffen Koschmieder
Hamostaseologie|February 13, 2020
How I Manage Thrombotic/Thromboembolic Complications in Myeloproliferative NeoplasmsSteffen Koschmieder
American Journal of Blood Research|March 21, 2012
Mouse models as tools to understand and study BCR-ABL1 diseasesSteffen Koschmieder, Mirle Schemionek
Seminars in Cancer Biology|August 6, 2017
Epigenetic dysregulation in chronic myeloid leukaemia: A myriad of mechanisms and therapeutic optionsSteffen Koschmieder, David Vetrie
Blood Reviews|June 8, 2020
Role of inflammation in the biology of myeloproliferative neoplasmsSteffen Koschmieder, Nicolas Chatain
Hamostaseologie|February 3, 2025
Thrombosis at Unusual Sites: Focus on Myeloproliferative Neoplasms and Paroxysmal Nocturnal HemoglobinuriaSteffen Koschmieder, Jens Panse
Oncotargets and Therapy|March 16, 2013
Profile of bosutinib and its clinical potential in the treatment of chronic myeloid leukemiaGunhild Keller-von Amsberg, Steffen Koschmieder
Cancers|August 19, 2020
Role of Inflammatory Factors during Disease Pathogenesis and Stem Cell Transplantation in Myeloproliferative NeoplasmsNicolas Chatain, Steffen Koschmieder, Edgar Jost
Proceedings of the National Academy of Sciences of the United States of America|September 15, 2020
Kindlin-3 loss curbs chronic myeloid leukemia in mice by mobilizing leukemic stem cells from protective bone marrow nichesPeter William Krenn, Steffen Koschmieder, Reinhard Fässler
Dermatologie (Heidelberg, Germany)|June 16, 2026
[Systemic pruritus: focus on hematological, nephrogenic, and hepatobiliary etiologies]Steffen Koschmieder, Marcus Brand, Andreas E Kremer
Pageof 20